Ferrer-Francesch X, Caro P, Alcalde L, Armengol M P, Ashhab Y, Lucas-Martín A, Martínez-Cáceres E M, Juan M, Pujol-Borrell R
Immunology (Laboratory of Immunology for Research Applied to Diagnosis (LIRAD), Blood and Tissue Bank, Institute for Health Sciences Research Germans Trias i Pujol, Badalona, Barcelona, Spain.
J Endocrinol Invest. 2006 Apr;29(4):342-9. doi: 10.1007/BF03344106.
Autoimmune thyroid diseases are characterized by lymphocytic infiltration of the thyroid gland. Chemokines are crucial in the recruitment of lymphocytes and might play an important role in the pathogenesis of autoimmune thyroid disease. The aim of this study was to test the feasibility of analysing by one-tube reverse-transcriptase polymerase chain reaction (RT-PCR) technique CC chemokine profiles in samples obtained by fine needle aspiration biopsy (FNAB). In 27 out of 35 (77%) samples, the material was sufficient for analysis and in 16 (59%) chemokines were detected, thus demonstrating the potential of this technique. Moreover, even in this small group, a statistically significant increase of CCL3 and CCL4 was found in samples from patients with autoimmune thyroid disease as compared to those with multinodular goiter. Chemokine profile measured by improved multiamplification techniques in FNAB thyroid samples may become a useful complementary tool for the management of thyroid autoimmune disease as it constitutes a source of data for research of their pathogenesis.
自身免疫性甲状腺疾病的特征是甲状腺出现淋巴细胞浸润。趋化因子在淋巴细胞的募集过程中起关键作用,可能在自身免疫性甲状腺疾病的发病机制中扮演重要角色。本研究的目的是测试通过单管逆转录聚合酶链反应(RT-PCR)技术分析细针穿刺活检(FNAB)获取样本中的CC趋化因子谱的可行性。35个样本中有27个(77%)的材料足以进行分析,其中16个(59%)检测到了趋化因子,从而证明了该技术的潜力。此外,即使在这个小样本组中,与多结节性甲状腺肿患者的样本相比,自身免疫性甲状腺疾病患者样本中的CCL3和CCL4在统计学上有显著增加。通过改进的多重扩增技术测量FNAB甲状腺样本中的趋化因子谱,可能成为甲状腺自身免疫性疾病管理的有用补充工具,因为它构成了研究其发病机制的数据来源。